FAKTOR-OPTIONSSCHEIN - RESMED | Real-time Bid/Ask 12:54:15 04/06/2024 BST | ||
| 13.49 EUR / 14.25 EUR | +4.68% |
|
| Current month | +11.72% | ||
| 1 month | +27.77% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 04/06/24 | 13.49 | +1.81% |
| 03/06/24 | 13.25 | +11.72% |
| 31/05/24 | 11.86 | -19.81% |
| 30/05/24 | 14.79 | +1.02% |
| 29/05/24 | 14.64 | +29.79% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 12:48 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | Morgan Stanley |
| WKN | MG3DQQ |
| ISIN | DE000MG3DQQ7 |
| Date issued | 30/04/2024 |
| Strike | 228.1 $ |
| Maturity | Unlimited |
| Parity | 1.47 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.79 € |
|---|---|
| Lowest since issue | 7.91 € |
| Spread | 0.76 € |
| Spread % | 5.34% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
207.4
USD
Average target price
216.6
USD
Spread / Average Target
+4.46%
- Stock Market
- Certificates
- Certificat